Fundraising Fox

Ferryx

Bristol, GB · 1 known investors

ferryx.com

Ferryx develops next-generation probiotics aimed at improving gut health for people experiencing active flare-ups of gut conditions. A 2019 spin-out from the University of Bristol, the company works to bring these probiotics into commercial production.

BiotechDeep TechHealthtechin /37188119@ferryx_bristol

Investors · 1

Companies House · registry record

View on Companies House ↗
Registered name
FERRYX LIMITED
Company number
12193693
Status
Active
Company type
Private limited company
Incorporated
6 Sept 2019
Registered office
Future Space Uwe North Gate, Filton Road, Stoke Gifford, Bristol, BS34 8RB
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts
last made up to 30 Sept 2025 · next due 30 Jun 2027
Confirmation statement
last made up to 18 Dec 2025 · next due 1 Jan 2027

Current officers · 4

  • Jennifer Ruth Bailey director, appointed 18 Nov 2019
  • Tristan Alexander Cogan director, appointed 18 Nov 2019
  • Le Roy Dowey director, appointed 18 May 2022
  • John Stephen Fox director, appointed 18 Nov 2019

Source: Companies House public register · retrieved 6 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.